V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20219854 | 20083765 | 1.74 | 47.1 | Adjuvant (A) | 2019-02-11 | 2019-02-12 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100721800 |
| 20219858 | 20083766 | 1.65 | 90 | Curative (C) | 2016-01-02 | 2016-01-16 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101462187 |
| 20219865 | 20083767 | 1.6 | 50.1 | Curative (C) | 2019-10-11 | 2019-11-07 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100037819 |
| 20219869 | 20083768 | 1.72 | 71.2 | null | 2017-08-23 | 2017-08-23 | Enzalutamide | null | null | CAPECITABINE + TEMOZOLOMIDE | 101694577 |
| 20219871 | 20083769 | 1.72 | 61.5 | Palliative (P) | 2017-05-30 | 2017-06-20 | Enzalutamide | 2 | N | LUTETIUM-177 | 100307023 |
| 20219877 | 20083770 | 1.64 | 89.7 | Palliative (P) | 2016-12-28 | 2017-01-07 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100483137 |
| 20219881 | 20083771 | 1.56 | 82.1 | Palliative (P) | 2015-12-17 | 2015-12-24 | Enzalutamide | 02 | N | ECF | 100022640 |
| 20219886 | 20083772 | null | 0 | Palliative (P) | 2021-08-26 | 2021-09-22 | Enzalutamide | N | N | OCTREOTIDE | 100791210 |
| 20219889 | 20083773 | 1.62 | 95.9 | Neo-adjuvant (N) | 2017-11-16 | 2017-11-23 | OCTREOTIDE | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100176802 |
| 20219890 | 20083774 | 1.58 | 66.1 | Neo-adjuvant (N) | 2016-06-20 | 2016-06-21 | Enzalutamide | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100133443 |
| 20219892 | 20083775 | 1.62 | 104 | Palliative (P) | 2018-02-15 | 2018-03-08 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101217790 |
| 20219897 | 20083776 | 1.65 | 90 | Palliative (P) | 2016-11-14 | 2016-11-15 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100999102 |
| 20219899 | 20083777 | null | 76.2 | 03 | 2017-04-11 | 2017-04-28 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101338915 |
| 20219902 | 20083778 | 0 | 87 | Curative (C) | 2021-04-21 | 2021-05-18 | Enzalutamide | 02 | N | TRASTUZUMAB | 101623288 |
| 20219903 | 20083779 | 1.8 | 100 | Palliative (P) | 2019-08-23 | 2019-08-29 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101474491 |
| 20219905 | 20083780 | 1.76 | 91.6 | Neo-adjuvant (N) | 2019-05-30 | 2019-06-13 | Enzalutamide | 02 | Y | ENZALUTAMIDE | 100129516 |
| 20219907 | 20083781 | 1.61 | 80 | null | 2017-12-20 | 2017-12-20 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + RT | 100999348 |
| 20219910 | 20083782 | 1.8 | 43 | Palliative (P) | 2022-04-12 | 2022-04-12 | Enzalutamide | 02 | N | CARBOPLATIN | 100187085 |
| 20219912 | 20083783 | 1.58 | 65.3 | Neo-adjuvant (N) | 2015-03-08 | 2015-03-08 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100171984 |
| 20219915 | 20083784 | 1.58 | 75.8 | Curative (C) | 2019-04-21 | 2019-05-11 | CARBOPLATIN + PACLITAXEL + RT | 02 | Y | CARBOPLATIN + PACLITAXEL + RT | 100545448 |
| 20219916 | 20083785 | 1.77 | 99.3 | Neo-adjuvant (N) | 2018-03-27 | 2018-03-28 | Enzalutamide | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100698220 |
| 20219917 | 20083786 | 1.73 | 85.3 | Palliative (P) | 2019-07-05 | 2019-07-05 | Enzalutamide | N | N | CETUXIMAB | 101839303 |
| 20219921 | 20083787 | 1.59 | 97.5 | Palliative (P) | 2019-10-08 | 2019-10-09 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101600035 |
| 20219922 | 20083788 | 1.76 | 72.8 | Palliative (P) | 2019-05-24 | 2019-05-25 | Enzalutamide | N | N | CETUXIMAB | 101749738 |
| 20219925 | 20083789 | 1.82 | 80.6 | Palliative (P) | 2017-06-27 | 2017-07-11 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100229698 |
| 20219926 | 20083790 | 1.83 | 56.25 | null | 2020-05-28 | 2020-05-28 | Enzalutamide | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 100647383 |
| 20219930 | 20083791 | 1.41 | 75 | Adjuvant (A) | 2015-06-26 | 2015-06-26 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101594380 |
| 20219937 | 20083792 | 1.83 | 55.2 | Curative (C) | 2016-07-17 | 2016-08-12 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100077941 |
| 20219940 | 20083793 | 1.5 | 47 | null | 2022-04-29 | 2022-05-09 | Enzalutamide | N | N | SCALOP-2 TRIAL | 100228502 |
| 20219948 | 20083794 | 1.7 | 70.2 | 03 | 2019-06-28 | 2019-07-19 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101108994 |
| 20219957 | 20083795 | 1.57 | 110 | null | 2019-02-01 | 2019-02-03 | Enzalutamide | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101752256 |
| 20219964 | 20083796 | 1.58 | 45.3 | Adjuvant (A) | 2020-01-02 | 2020-01-02 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 100887297 |
| 20219971 | 20083797 | 1.5 | 84.7 | Palliative (P) | 2019-03-10 | 2019-03-10 | Enzalutamide | N | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101862101 |
| 20219972 | 20083798 | 1.7 | 64.9 | Palliative (P) | 2016-02-18 | 2016-02-19 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100740926 |
| 20219975 | 20083799 | 1.62 | 99 | Palliative (P) | 2018-12-16 | 2018-12-17 | Enzalutamide | N | N | SCALOP-2 TRIAL | 100179707 |
| 20219978 | 20083800 | 1.62 | 43 | Palliative (P) | 2017-01-19 | 2017-02-15 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100119913 |
| 20219988 | 20083801 | 1.7 | 95 | Palliative (P) | 2018-09-01 | 2018-09-01 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101045695 |
| 20219994 | 20083802 | 1.78 | 71.6 | null | 2018-08-28 | 2018-10-18 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 101056989 |
| 20219995 | 20083803 | 1.58 | 85.4 | null | 2017-09-03 | 2017-09-03 | Enzalutamide | 02 | null | ENZALUTAMIDE | 100621883 |
| 20219996 | 20083804 | 1.61 | 79.2 | Palliative (P) | 2018-08-04 | 2018-08-05 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100291848 |
| 20219997 | 20083805 | 0 | 0 | Palliative (P) | 2017-09-09 | 2017-09-09 | Capecitabine + Cisplatin + RT | 02 | N | CETUXIMAB | 100628225 |
| 20220000 | 20083806 | 1.81 | 47 | Palliative (P) | 2017-10-06 | 2017-10-07 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100866243 |
| 20220003 | 20083807 | 1.64 | 73.4 | Palliative (P) | 2019-04-22 | 2019-05-06 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101370525 |
| 20220004 | 20083808 | 1.78 | 67 | Curative (C) | 2016-08-02 | 2016-08-03 | Enzalutamide | 02 | N | CISPLATIN | 100372738 |
| 20220005 | 20083809 | 1.78 | 64.2 | Neo-adjuvant (N) | 2018-02-25 | 2018-02-25 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + GEMCITABINE | 100312958 |
| 20220006 | 20083810 | 1.7 | 59.6 | Palliative (P) | 2018-05-10 | 2018-06-17 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101856508 |
| 20220009 | 20083811 | 1.73 | 0 | Palliative (P) | 2016-05-11 | 2016-05-18 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101320671 |
| 20220011 | 20083812 | null | 76 | Palliative (P) | 2019-01-04 | 2019-01-07 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100227723 |
| 20220015 | 20083813 | 1.93 | 53.25 | Neo-adjuvant (N) | 2017-04-22 | 2017-04-23 | Enzalutamide | 02 | Y | SCALOP-2 TRIAL | 101542608 |
| 20220017 | 20083814 | 1.74 | null | Palliative (P) | 2016-07-23 | 2016-07-27 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100612432 |